Effectiveness of covid-19 vaccines against delta (B.1.617.2) variant: A systematic review and meta-analysis of clinical studies

Effectiveness of covid-19 vaccines against delta (B.1.617.2) variant: A systematic review and meta-analysis of clinical studies

The high transmissibility, mortality, and morbidity rate of the SARS-CoV-2 Delta (B.1.617.2) variant have raised concerns regarding vaccine effectiveness (VE). To address this issue, all publications relevant to the effectiveness of vaccines against the Delta variant were searched in the Web of Scie...

Full description

Bibliographic Details
Main Authors: Djalalinia, S. (Author), Ghorbani, S. (Author), Kasaeian, A. (Author), Khatami, A. (Author), Mardani-Fard, H.A (Author), Mohammadi, M. (Author), Mousavi, S.A (Author), Neshin, S.A.S (Author), Pormohammad, A. (Author), Turner, D.L (Author), Turner, R.J (Author), Zarei, M. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
ad26.cov2.s vaccine
bnt162b2 mrna 1273 ad26 cov2 s
comirnaty
corona vac
coronavac
coronavirus disease 2019
covaxin
COVID-19
Delta variant
Effectiveness
Efficacy
elasomeran
genetic variation
hospitalization
human
meta analysis
Meta-analysis
public health
Review
RNA vaccine
SARS-CoV-2
SARS-CoV-2 B.1.617.2 variant vaccines
SARS-CoV-2 variants
Severe acute respiratory syndrome coronavirus 2
severe acute respiratory syndrome vaccine
Side effect
systematic review
vaccination
vaxzevria
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items